abstract |
The present invention relates to a novel heterocyclic derivative compound and a use thereof and, more particularly, to a novel heterocyclic derivative compound having selective inhibitory activity against a fibroblast growth factor receptor (FGFR) And a pharmaceutical composition for preventing or treating various diseases associated with the FGFR. |